Pharmozyme Inc.

1190 Mountain View Alviso Rd., Suite H
Sunnyvale,  CA  94089

United States
http://www.pharmozyme.com
  • Booth: 514

Profile

Pharmozyme has developed proprietary technology to produce the world’s purest reagents, introducing the first Taq Polymerase absolutely free from bacterial and animal DNA contamination. Pharmozyme’s mission is to significantly improve the lives of human beings through the development of novel, effective, and accessible solutions for the biotech community. By providing the highest quality enzymes and customer service, we strive to help genetic research and diagnostic labs thrive.


 Press Releases

  • In 2016 the team at Pharmozyme made a break through. Developing a proprietary platform, gene amplification enzymes were re-envisioned for the next generation of amplification and sequencing technologies. Taq Polymerase, a major player in biotechnology, was the first product to be produced in Pharmozyme’s new platform.

    For decades researchers, scientists, and diagnostics professionals have lamented the level of background contamination in reagents and amplification enzymes. Costing millions in misdiagnosis and re-tests, background contamination often leads to false positives or inaccurate results in PCR based procedures. Often produced in an E.Coli host, PCR enzymes are almost always contaminated with bacterial background DNA. Tests have revealed that even the purest marketed “Low-DNA” enzyme carry significant background contamination… until now!

    Pharmozyme is proud to introduce Crystal Taq Polymerase, a Taq polymerase absolutely free from animal and bacterial background DNA. Produced in a new host and purified with proprietary technology, extensive validation has shown the product to be the purest gene amplification enzyme available in the market.

    Pharmozyme is committed to improving the lives of human beings through the development of novel, effective, and accessible solutions for the biotech community. Seeking new partnerships and collaboration, the team at Pharmozyme welcomes new ideas and relationships in the pursuit of creating better diagnostic kits and platforms. 

    Crystal Taq Polymerase is offered both as a standalone enzyme as well as a variety of master mixes. For more information please visit www.pharmozyme.com


 Additional Info

Included in the Export Interest Directory?
Yes
Business Needs:
Direct Sales, Distributor/Agent/Representative, Investor, Joint Ventures, Licensing Agreements
Products to be exported:
Crystal Taq Polymerase,
 Crystal Taq PCR Master Mix (2X)
 Crystal Taq SybrGreen Master Mix
 Crystal Taq EvaGreen Master Mix
 Samurai Taq Polymerase
Countries of Interest:
Afghanistan, Albania, Algeria, American Samoa, Andorra, Angola, Anguilla, Antarctica, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Bouvet Island, Brazil, British Indian Ocean Territory, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Cayman Islands, Central African Republic, Chad, Chile, China, Christmas Island, Cocos (Keeling Islands), Colombia, Comoros, Congo, Cook Islands, Costa Rica, Cote D'Ivoire (Ivory Coast), Croatia (Hrvatska), Cuba, Cyprus, Czech Republic, Denmark, Djibouti, Dominica, Dominican Republic, East Timor, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Ethiopia, Falkland Islands (Malvinas), Faroe Islands, Fiji, Finland, France, France, Metropolitan, French Guiana, French Polynesia, French Southern Territories, Gabon, Gambia, Georgia, Germany, Ghana, Gibraltar, Greece, Greenland, Grenada, Guadeloupe, Guam, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Heard and McDonald Islands, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, Korea (North), Korea (South), Kosovo, Kuwait, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Macau, Macedonia, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Martinique, Mauritania, Mauritius, Mayotte, Mexico, Micronesia, Moldova, Monaco, Mongolia, Montenegro, Montserrat, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, Netherlands Antilles, New Caledonia, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norfolk Island, Northern Mariana Islands, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Pitcairn, Poland, Portugal, Puerto Rico, Qatar, Reunion, Romania, Russian Federation, Rwanda, S. Georgia and S. Sandwich Isls., Saint Kitts and Nevis, Saint Lucia, Saint Vincent and The Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovak Republic, Slovenia, Solomon Islands, Somalia, South Africa, Spain, Sri Lanka, St. Helena, St. Pierre and Miquelon, Sudan, Suriname, Svalbard and Jan Mayen Islands, Swaziland, Sweden, Switzerland, Syria, Taiwan, Tajikistan, Tanzania, Thailand, Togo, Tokelau, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Turks and Caicos Islands, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom, United States, Uruguay, US Minor Outlying Islands, Uzbekistan, Vanuatu, Vatican City State, Venezuela, Vietnam, Virgin Islands (British), Virgin Islands (US), Wallis and Futuna Islands, Western Sahara, Yemen, Yugoslavia, Zaire, Zambia, Zimbabwe